logo

ENVB

Enveric Biosciences·NASDAQ
--
--(--)
--
--(--)

ENVB fundamentals

Enveric Biosciences (ENVB) released its earnings on Nov 14, 2025: revenue was -- (YoY --), beat estimates; EPS was -10.81 (YoY +74.98%), beat estimates.
Revenue / YoY
--
--
EPS / YoY
-10.81
+74.98%
Report date
Nov 14, 2025
EPS
Q4,undefined
Q1,2018
Q2,2018
Q3,2018
Q4,undefined
Q1,undefined
Q2,undefined
Q1,undefined
Q3,undefined
Q4,undefined
Q4,2021
Q2,2022
Q3,2022
Q1,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Q3,2025
Actual
-2790-790.2-561.6-415.8-234-262.8-109.8-41.4-43.2-57.96-14.64-11.64-10.81
Forecast
-1440-675-630-401.4-376.2-284.4-139.5-99-93.6-41.4-72-63-63
Surprise
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-93.75%
-17.07%
+10.86%
-3.59%
+37.80%
+7.59%
+21.29%
+58.18%
+53.85%
-40.00%
+79.67%
+81.52%
+82.84%
Revenue
Q4,undefined
Q1,2018
Q2,2018
Q3,2018
Q4,undefined
Q1,undefined
Q2,undefined
Q1,undefined
Q3,undefined
Q4,undefined
Q4,2021
Q2,2022
Q3,2022
Q1,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Q3,2025
Actual
----------------------------0000--0------
Forecast
--------------------0000000000------
Surprise
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Earnings Call